It's interesting to note that it can considerably prolong the relapse time in MS patients by lowering the levels of pro-inflammatory factor IFN-γ and raising the levels of anti-inflammatory factors IL-35 and IL-10 when paired with methylprednisolone (283). Here, IFNG is linked to myeloid sarcoma.